Medications like semaglutide and tirzepatide mimic this hormone at levels far higher than the body normally produces on its own
A licensed provider should review your intake, order labs if needed, and stay involved with dose adjustments and side-effect management, not just write a one-time prescription
Before you begin the process, always review your prescription label carefully and confirm that your medication is intended for subcutaneous use
However, doctors keep a close watch on patients who have had pancreatitis in the past
ONCOLOGY Vol 39, Issue 7 Volume 39 Issue 7 Pages: 294-296 GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer Sherry Shen, MD , Bethina Liu, MD , Chad Fanti, MD Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population